What is orencia?

What is Orencia?

Orencia is the brand name for abatacept, a prescription medication used to treat rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis. It works by blocking certain signals in the immune system that trigger inflammation and attack on joints.

Why do doctors prescribe Orencia instead of TNF inhibitors?

Doctors often turn to Orencia when patients do not respond well to TNF inhibitors such as Humira or Enbrel. Orencia takes a different approach by targeting T-cell activation rather than blocking tumor necrosis factor, a pathway that can help patients who have already failed first-line biologic treatments.

How does Orencia work in the body?

Abatacept binds to CD80 and CD86 proteins on antigen-presenting cells and prevents them from activating T-cells. This later-stage intervention in the immune cascade explains why Orencia holds a position on guidelines as a second-line biologic after TNF failure.

When does the Orencia patent expire?

The composition-of-matter patent for abatacept expires in 2026. Related patents covering formulations and methods of use extend protection until 2032. Companies are already preparing biosimilar versions of Orencia.